This study wants to focus on Carcinoma detection rates with blue laser imaging (BLI) for
      participants with head-neck cancer who need a percutaneous endoscopic gastrostomy (PEG). BLI
      is a new imaging technique that can easily be used within a standard gastroscopy.

Blue Laser Imaging (BLI) for Detection of Secondary Head and Neck Cancer

Head Neck Cancer

Esophageal Cancer

Gastrostomy

Head-Neck cancers are a significant burden all around the world. Patients suffering from one
      tumor are at high risk for a second cancer or another precancerous lesion. Before or during
      cancer treatment a PEG is needed to maintain a sufficient calories intake. PEG is established
      by performing a standard gastroscopy.

      This randomised study wants to compare the detection rates of standard white light endoscopy
      compared to the additional use of blue laser imaging for second cancers or precancerous
      lesions in participants presenting for PEG establishment.

blue laser imaging

Detection Rate by Blue Laser Imaging (BLI) of Secondary or Early Squamous Head and Neck Cancer in Patients Undergoing Elective Percutaneous Endoscopic Gastrostomy (PEG)

The detection rates for malignant or premalignant lesions in participants with head neck tumors will be compared when using BLI and white light endoscopy

Record Keeper

In this group the participants will be examined by white light endoscopy first and secondly with blue laser imaging technique during the same gastroscopy.

In this group the participants will be examined by blue laser imaging technique first and secondly with standard white light during the same gastroscopy.

Blue Laser Imaging (BLI) for Detection of Secondary Head and Neck Cancer

About this trial

Study ID

Status

Type

Phase

Placebo

Accepting

Not accepting

Trial Timing

What is this trial about?

What are the participation requirements?

Locations

Location

Status